Literature DB >> 22438562

Increased protection from vaccinia virus infection in mice genetically prone to lymphoproliferative disorders.

Mina O Seedhom1, Keisha S Mathurin, Sung-Kwon Kim, Raymond M Welsh.   

Abstract

Mutations in the genes that encode Fas or Fas ligand (FasL) can result in poor restraints on lymphocyte activation and in increased susceptibility to autoimmune disorders. Because these mutations portend a continuously activated immune state, we hypothesized that they might in some cases confer resistance to infection. To examine this possibility, the immune response to, morbidity caused by, and clearance of vaccinia virus (VACV) Western Reserve was examined in 5- to 7-week-old Fas mutant (lpr) mice, before an overt lymphoproliferative disorder was observable. On day 6 after VACV infection, C57BL/6-lpr (B6-lpr) mice had decreased morbidity, decreased viral titers, and an increased percentage and number of CD4(+) and CD8(+) T cells. As early as day 2 after infection, B6-lpr mice had decreased liver and spleen viral titers and increased numbers of and increased gamma interferon (IFN-γ) production by several different effector cell populations. Depletion of individual effector cell subsets did not inhibit the resistance of B6-lpr mice. Uninfected B6-lpr mice also had increased numbers of NK cells, γδ(+) T cells, and CD44(+) CD4(+) and CD44(+) CD8(+) T cells compared to uninfected B6 mice. Antibody to IFN-γ resulted in increased virus load in both B6 and B6-lpr mice and eliminated the differences in viral titers between them. These results suggest that IFN-γ produced by multiple activated leukocyte populations in Fas-deficient hosts enhances resistance to some viral infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22438562      PMCID: PMC3372224          DOI: 10.1128/JVI.07176-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.

Authors:  D Moskophidis; F Lechner; H Pircher; R M Zinkernagel
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

2.  Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide.

Authors:  J H Russell; B Rush; C Weaver; R Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

3.  Elevated production of interferon-gamma and interleukin 4 by mature T cells from autoimmune lpr mice correlates with Pgp-1 (CD44) expression.

Authors:  R C Budd; J H Schumacher; G Winslow; T R Mosmann
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

4.  The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma.

Authors:  J Ruby; I Ramshaw
Journal:  Lymphokine Cytokine Res       Date:  1991-10

5.  Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system.

Authors:  Bimmi Shrestha; Michael S Diamond
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

6.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

7.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

8.  Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.

Authors:  L Farre; A L Bittencourt; G Silva-Santos; A Almeida; A C Silva; D Decanine; G M Soares; L C Alcantara; S Van Dooren; B Galvão-Castro; A M Vandamme; J Van Weyenbergh
Journal:  J Leukoc Biol       Date:  2007-10-25       Impact factor: 4.962

9.  Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.

Authors:  Yong Jin Jung; Yoon Jun Kim; Lyoung Hyo Kim; Soo Ok Lee; Byung Lae Park; Hyoung Doo Shin; Hyo-Suk Lee
Journal:  Intervirology       Date:  2007-10-15       Impact factor: 1.763

10.  Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.

Authors:  E Rouvier; M F Luciani; P Golstein
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Staying alive: cell death in antiviral immunity.

Authors:  Jason W Upton; Francis Ka-Ming Chan
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

2.  Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin.

Authors:  Heather D Hickman; Glennys V Reynoso; Barbara F Ngudiankama; Erica J Rubin; Javier G Magadán; Stephanie S Cush; James Gibbs; Barbara Molon; Vincenzo Bronte; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Host Microbe       Date:  2013-02-13       Impact factor: 21.023

3.  CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Authors:  John Goulding; Georges Abboud; Vikas Tahiliani; Pritesh Desai; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

4.  MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia.

Authors:  Pedro Henrique Alves da Silva; Samantha Xing; Andriana G Kotini; Eirini P Papapetrou; Xiaoyu Song; Kai W Wucherpfennig; John Mascarenhas; Lucas Ferrari de Andrade
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.